Vkt Pharma Profile
Key Indicators
- Authorised Capital ₹ 12.00 Cr
as on 14-12-2024
- Paid Up Capital ₹ 11.06 Cr
as on 14-12-2024
- Company Age 18 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 140.00 Cr
as on 14-12-2024
- Satisfied Charges ₹ 225.79 Cr
as on 14-12-2024
- Revenue -39.05%
(FY 2022)
- Profit -522.52%
(FY 2022)
- Ebitda -121.26%
(FY 2022)
- Net Worth 15.07%
(FY 2022)
- Total Assets 7.30%
(FY 2022)
About Vkt Pharma
The Corporate was formerly known as Potluri Builders Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 12.00 Cr and a paid-up capital of Rs 11.06 Cr.
The company currently has active open charges totaling ₹140.00 Cr. The company has closed loans amounting to ₹225.79 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Vkt Pharma Private Limited India is Shivangi Jain as COMPANY SECRETARY. Ramesh Potluri, Hima Potluri, and Vamsi Potluri serve as directors at the Company.
- CIN/LLPIN
U24100TG2006PTC050221
- Company No.
050221
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 May 2006
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Vkt Pharma Private Limited offer?
Vkt Pharma Private Limited offers a wide range of products and services, including .
Who are the key members and board of directors at Vkt Pharma?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vamsi Potluri  | Managing Director | 16-Aug-2014 | Current |
| Shivangi Jain | Company Secretary | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramesh Potluri | Director | 31-May-2006 | Current |
| Hima Potluri | Director | 31-May-2006 | Current |
Financial Performance and Corporate Structure Insights of Vkt Pharma.
Vkt Pharma Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 39.05% decrease. The company also saw a substantial fall in profitability, with a 522.52% decrease in profit. The company's net worth Soared by an impressive increase of 15.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vkt Pharma?
In 2022, Vkt Pharma had a promoter holding of 73.42% and a public holding of 26.58%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sms Pharmaceuticals LimitedActive 37 years 6 daysRamesh Potluri and Vamsi Potluri are mutual person
- Sms Peptides Private LimitedActive 1 month 17 days
Ramesh Potluri and Vamsi Potluri are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Sep 2024 | ₹10.00 Cr | Open |
Others Creation Date: 02 Nov 2023 | ₹130.00 Cr | Open |
Others Creation Date: 02 Feb 2018 | ₹25.00 Cr | Satisfied |
How Many Employees Work at Vkt Pharma?
Vkt Pharma has a workforce of 238 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vkt Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vkt Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
